Clinical Trial Update: Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing doxorubicin or epirubicin with cyclophosphamide in older women with invasive breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Epirubicin (epirubicin)

Snippet

Sponsor: Charing Cross Hospital | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN